Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.
Feature | Udi Nussinovitch M.D., Ph.D.

This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...

Home October 09, 2020
Home
Videos | Radial Access

Jordan G. Safirstein, M.D., FACC, FSCAI, director of transradial catheterization for Atlantic Health System’s Morristown ...

Home October 07, 2020
Home
News | VIVA

October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...

Home October 05, 2020
Home
News | Heart Valve Technology

October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...

Home October 02, 2020
Home
Videos | Left Atrial Appendage (LAA) Occluders

Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal ...

Home October 02, 2020
Home
News | Hybrid OR

October 2, 2020 — The new cardiac hybrid operating room (OR) at London Health Sciences Centre (LHSC) in London, Ontario ...

Home October 02, 2020
Home
News | Stents

October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual ...

Home October 01, 2020
Home
News | Optical Coherence Tomography (OCT)

October 1, 2020 — A team of researchers led by the University of Adelaide and University of Stuttgart has used 3-D micro ...

Home October 01, 2020
Home
The two top DAIC stories in September included the use of point-of-care ultrasound (POCUS) to perform echocardiograms of COVID-19 patients rather than wheeling in larger systems that are more difficult to sanitize. The second top story was on a new trial for Abbott's bioresorbable stent for below-the-knee (BTK) peripheral artery disease lesions. This is a resumption of bioresorbable stent clinical research since the Absorb stent was taken off the market in 2017.
Feature | Dave Fornell, Editor

October 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home October 01, 2020
Home
News | Thrombectomy Devices

September 25, 2020 — Philips Healthcare launched its QuickClear mechanical thrombectomy system. The compact, single-use ...

Home September 25, 2020
Home
News | Heart Failure

September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN) ...

Home September 23, 2020
Home
Videos | Artificial Intelligence

Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...

Home September 21, 2020
Home
TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT
Feature | TCT

October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular ...

Home October 15, 2020
Home
Subscribe Now